BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2690835)

  • 1. [Is fibrocystic disease precancerous?].
    De León Antoni E
    Bol Asoc Med P R; 1989 Nov; 81(11):451-4. PubMed ID: 2690835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is 'fibrocystic disease' of the breast precancerous? A consensus report from the College of American Pathologists.
    Indiana Med; 1986 Sep; 79(9):753-4. PubMed ID: 3772069
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions.
    Masood S
    Clin Lab Med; 2005 Dec; 25(4):713-31, vi. PubMed ID: 16308088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up.
    Seidman JD; Ashton M; Lefkowitz M
    Cancer; 1996 Jun; 77(12):2529-37. PubMed ID: 8640702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is 'fibrocystic disease' of the breast precancerous?
    Arch Pathol Lab Med; 1986 Mar; 110(3):171-3. PubMed ID: 3606334
    [No Abstract]   [Full Text] [Related]  

  • 6. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triad of columnar cell alteration, lobular carcinoma in situ, and tubular carcinoma of the breast.
    Sahoo S; Recant WM
    Breast J; 2005; 11(2):140-2. PubMed ID: 15730461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphology, topography and growth pattern of benign proliferative breast lesions and pre-invasive cancers].
    Böcker W; Jarasch ED; Nagle EB; Höhne R
    Verh Dtsch Ges Pathol; 1985; 69():96-107. PubMed ID: 3006396
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of proliferative breast lesions around breast cancers].
    Moriya T; Manabe T; Sakurai T; Sakamoto K
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():42-5. PubMed ID: 7747991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial dysplasia in nipple aspirates of breast fluid: association with family history and other breast cancer risk factors.
    Petrakis NL; Ernster VL; King EB; Sacks ST
    J Natl Cancer Inst; 1982 Jan; 68(1):9-13. PubMed ID: 6948129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypia in the assessment of breast cancer risk: implications for management.
    Vogel VG
    Diagn Cytopathol; 2004 Mar; 30(3):151-7. PubMed ID: 14986294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histology, normal borderline forms and pathologic proliferation patterns of the breast].
    Holzner JH
    Verh Dtsch Ges Pathol; 1985; 69():26-50. PubMed ID: 4096107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Morphometric analysis of fibrocystic breast disease].
    Guski H; Freitag A; Hufnagl P; Voss K; Wenzelides K; Simon H
    Zentralbl Allg Pathol; 1986; 132(4):293-300. PubMed ID: 3026118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Definition and development of "borderline" lesions in breast cancer. Atypical hyperplasia and carcinoma "in situ"].
    Contesso G
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):101-2. PubMed ID: 7451846
    [No Abstract]   [Full Text] [Related]  

  • 16. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
    Shirley SE
    West Indian Med J; 1999 Dec; 48(4):173-8. PubMed ID: 10639833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign breast disease and the risk of breast cancer in the next 15 years.
    Socolov D; Anghelache I; Ilea C; Socolov R; Carauleanu A
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):135-40. PubMed ID: 25970956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is fibrocystic disease of the breast precancerous?
    Godfrey SE
    Arch Pathol Lab Med; 1986 Nov; 110(11):991. PubMed ID: 3778132
    [No Abstract]   [Full Text] [Related]  

  • 19. [Benign and premalignant breast lesions--clinico-pathological correlation].
    Afek A; Shibi R; Kopolovitz G
    Harefuah; 1997 Nov; 133(9):375-8. PubMed ID: 9418343
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathology, systematic aspects and classification of benign breast diseases].
    Bässler R; Kind M
    Gynakologe; 1989 Aug; 22(4):216-25. PubMed ID: 2676756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.